TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in cellular structure and movement.
Preclinical research has examined TB-500 in relation to actin regulation (a key component of the cell cytoskeleton), cell migration, and tissue-repair models. It is frequently studied alongside BPC-157 in recovery-research contexts, which is why the two are often presented together as a research blend.
As with other peptides in this category, the evidence base is preclinical and TB-500 is not an approved medicine. It is handled strictly as a research material.
Each vial is supplied lyophilised and HPLC-tested to at least 99% purity.
This article is provided for educational and research-reference purposes only. It is not medical advice. All products are supplied strictly for in-vitro laboratory research use, not for human or veterinary consumption.